SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026

Other non-cash items of $1.71M in Q1 FY2026

Q1 FY2026 other non-cash items was $1.71M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.71M+456.5% QoQ
Last fiscal yearDec 2025
$1.32M— YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
1.32M USD
Year-over-year change
—

Other Non-Cash Items vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Other Non-Cash Items for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BLCOBausch + Lomb CorporationLTM Jun 2026$172.63M USD+48.6%—3.2%
ALCAlcon Inc.LTM Sep 2026$159.73M USD+198.4%—1.5%
GKOSGlaukos CorporationLTM Jun 2026$73.8M USD+428.1%+57.1%12.0%
OCSOculis Holding AGLTM Mar 2026CHF 20.45M CHF-15.8%+34.6%4057.5%
STAASTAAR Surgical CompanyLTM Apr 2026$20.34M USD+239.8%+125.9%7.0%
OCULOcular Therapeutix, Inc.LTM Mar 2026$8.22M USD+1770.1%—15.8%
RXSTRxSight, Inc.LTM Mar 2026$5.99M USD-37.0%+301.8%4.7%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$3.96M USD-88.2%—52.0%
SGPSpyGlass Pharma, Inc. Common StockFY2025$1.32M USD———
SGHTSight Sciences, Inc.LTM Mar 2026$834K USD-92.4%-11.7%1.0%
Peer median (excluding SGP) —+48.6%+57.1%7.0%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.